Site identity card

Centre Hospitalier Universitaire de Martinique

Fort-de-France, France
Share

Networks

Clinical Studies (2)

  • CARBO : Study aims to identify demographic, clinical, biological, virologic, immunologic and genetic factors associated with or predictive of severe complications of arbovirus infections in a cohort of children and adults with confirmed arbovirus infections
  • CoCoPrev : Study aims to assess the impact of monoclonal antibodies and direct antiviral therapies on clinical and virological outcomes in high-risk patients with early mild-to-moderate COVID-19, including sequencing to identify viral population changes and emerging minority variants.

Study Data

  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Fragile population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • Emergency department
  • SARS-CoV-2
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Dengue virus
  • Zika virus
  • West Nile virus
  • Japanese encephalitis virus
  • Acute COVID-19
  • Arboviral disease
  • Vector-borne disease
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to